Profile
| Metric | Value |
|---|---|
| Full Name | Tempus AI, Inc. |
| Ticker | NASDAQ: TEM |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Health Information Services |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | tempus.com |
| Employees | 2,400 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $62.36 | |
| Price, 1D Change | +5.61% | |
| Market Cap | $11B | |
| - | ||
| PE Ratio | - | |
| Beta | 2.56 | |
| Revenue | $693M | |
| Revenue, 1Y Change | +30.38% | |
| EPS | -$4.60 | |
| EPS, 1Y Change | -166.85% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$4.60 | |
| EPS Estimate | -$0.62 | |
| EPS Est. Change | +86.59% | |
| Revenue | $693.40M | |
| Revenue Estimate | $1.26B | |
| Revenue Est. Change | +82.38% | |
| Current Price | $62.36 | |
| Price Target | - | $86.50 |
| Price Tgt. Change | - | +38.71% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.78 | -$4.60 | -157.97% | |
| -$0.62 | N/A | +86.59% | |
| -$0.47 | N/A | +89.79% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $695.53M | $693.40M | -0.31% | |
| $1.26B | N/A | +82.38% | |
| $1.57B | N/A | +126.86% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +82.07% | |
| Price, 3Y | - | |
| Market Cap, 1Y | +95.28% | |
| Market Cap, 3Y | - | |
| Revenue, 1Y | +30.38% | |
| Revenue, 3Y | +168.91% | |
| EPS, 1Y | -166.85% | |
| EPS, 3Y | -162.65% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $62.36 | |
| SMA 200 | $67.86 | |
| SMA 200 vs Price | +8.82% | |
| SMA 50 | $73.56 | |
| SMA 50 vs Price | +17.97% | |
| Beta | 2.56 | |
| ATR | $3.22 | |
| 14-Day RSI | 37.78 | |
| 10-Day Volatility | 48.54% | |
| 1-Year Volatility | 94.69% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $5.63M | |
| Payout Ratio | -0.80% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $693.40M | |
| EPS | -$4.60 | |
| Gross Profit | $381.11M | |
| Gross Margin | 54.96% | |
| Operating Profit | -$691.08M | |
| Operating Margin | -99.67% | |
| Net Income | -$705.81M | |
| Net Margin | -101.79% | |
| EBITDA | -$610.42M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 7.73 | |
| Current Ratio | 2.29 | |
| Quick Ratio | 2.16 | |
| Interest Coverage | -12.07 | |
| F-Score | 2 | |
| Altman Z-Score | 3.15 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | 9.80 | |
| PB Ratio | 21.33 | |
| EV/EBITDA | -77.09 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $56.34M | |
| Cash & Equivalents | $340.95M | |
| Total Assets | $926.12M | |
| Current Assets | $667.60M | |
| Total Liabilities | $869.78M | |
| Current Liabilities | $291.07M | |
| Total Debt | $468.09M | |
| Short Term Debt | $6.46M | |
| Accounts Payable | $53.80M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $1.38B | |
| Operating Expenses | $1.07B | |
| Cost Of Goods Sold | $312.29M | |
| SG&A | $755.35M | |
| D&A | $37.25M | |
| Interest Expense | $53.65M | |
| Income Tax | $266.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | -$189.05M | |
| CFI | -$130.39M | |
| CFF | $494.33M | |
| Capex | $22.12M | |
| Free Cash Flow | -$211.17M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Canaccord Genuity | → | |
| JP Morgan | → | |
| Morgan Stanley | → | |
| BTIG | → | |
| Piper Sandler | → | |
| Morgan Stanley | → | |
| HC Wainwright & Co. | → | |
| Needham | → | |
| Canaccord Genuity | → | |
| BTIG | → |
Analyst sentiment
Institutional ownership
Screeners with TEM
Data Sources & References
- TEM Official Website www.tempus.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1717115/000119312525264652/0001193125-25-264652-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1717115/000095017025025603/0000950170-25-025603-index.htm
- TEM Profile on Yahoo Finance finance.yahoo.com/quote/TEM
- TEM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tem
FAQ
What is the ticker symbol for Tempus AI, Inc.?
The ticker symbol for Tempus AI, Inc. is NASDAQ:TEM
Does Tempus AI, Inc. pay dividends?
No, Tempus AI, Inc. does not pay dividends
What sector is Tempus AI, Inc. in?
Tempus AI, Inc. is in the Healthcare sector
What industry is Tempus AI, Inc. in?
Tempus AI, Inc. is in the Health Information Services industry
What country is Tempus AI, Inc. based in?
Tempus AI, Inc. is headquartered in United States
When did Tempus AI, Inc. go public?
Tempus AI, Inc. initial public offering (IPO) was on June 14, 2024
Is Tempus AI, Inc. in the S&P 500?
No, Tempus AI, Inc. is not included in the S&P 500 index
Is Tempus AI, Inc. in the NASDAQ 100?
No, Tempus AI, Inc. is not included in the NASDAQ 100 index
Is Tempus AI, Inc. in the Dow Jones?
No, Tempus AI, Inc. is not included in the Dow Jones index
When was Tempus AI, Inc. last earnings report?
Tempus AI, Inc.'s most recent earnings report was on November 4, 2025
When does Tempus AI, Inc. report earnings?
The next expected earnings date for Tempus AI, Inc. is February 24, 2026